1. Home
  2. APYX vs ACRV Comparison

APYX vs ACRV Comparison

Compare APYX & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$3.86

Market Cap

85.0M

Sector

Health Care

ML Signal

HOLD

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

HOLD

Current Price

$2.53

Market Cap

82.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
ACRV
Founded
1982
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.0M
82.7M
IPO Year
1987
2022

Fundamental Metrics

Financial Performance
Metric
APYX
ACRV
Price
$3.86
$2.53
Analyst Decision
Buy
Buy
Analyst Count
1
5
Target Price
$8.00
$14.67
AVG Volume (30 Days)
120.7K
531.6K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$47,902,000.00
N/A
Revenue This Year
$8.50
N/A
Revenue Next Year
$7.18
$805.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$1.05
52 Week High
$4.44
$8.00

Technical Indicators

Market Signals
Indicator
APYX
ACRV
Relative Strength Index (RSI) 51.41 59.17
Support Level $3.92 $2.44
Resistance Level $4.14 $2.73
Average True Range (ATR) 0.19 0.17
MACD -0.05 0.01
Stochastic Oscillator 15.22 64.91

Price Performance

Historical Comparison
APYX
ACRV

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

Share on Social Networks: